2m 2m 2m 2m 2m 2m 2m
ZENTALIS PHARMA (ZNTL)
NASDAQ
$3.83$0.00 (0.00%)
Price as of Aug 21, 2026 7:30 PM EDT- $362.1MMarket Cap
- 92.21%1-Year Change
- BiotechnologyIndustry
ZENTALIS PHARMA (ZNTL)
$3.83$0.00 (0.00%)
ZNTL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.83 | ||
Change | -$0.01 (-0.39%) | ||
Open | $3.95 | ||
High | $3.95 | ||
Low | $3.81 | ||
Previous Close | $3.84 | ||
Volume | 741,800 | ||
30-Day Average Volume | 1,179,983 | ||
1-Week Change | 7.44% | ||
1-Month Change | -23.65% | ||
1-Year Change | 92.21% | ||
3-Year Change | -84.99% | ||
5-Year Change | -93.08% | ||
Fundamentals | |||
Shares Outstanding | 94.7M | ||
Total Assets | $215.3M | ||
Market Cap | $362.1M | ||
Enterprise Value | $337.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$42.3M | ||
Free Cash Flow | -$37.2M | ||
EBIT | -$42.1M | ||
EBITDA | -$42.0M | ||
Net Working Capital | $143.7M | ||
EPS | -$0.59 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -10 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue